Results 131 to 140 of about 18,708 (185)

Impact of sacubitril/valsartan on cardiac structure and function in post-acute myocardial infarction heart failure patients aged over 65: a single-center experience. [PDF]

Am J Transl Res
Yang L, Li J, Tian H, Yu Z, Tian K, Zhang C, Zhang J, Liu Y, Zhang M, Jia G.   +9 more
europepmc   +1 more source

A Comprehensive Physicochemical Analysis Focusing on the Characterization and Stability of Valsartan Silver Nano-Conjugates. [PDF]

Int J Mol Sci
Qadir A, Hasan KS, Bux K, Hasan KA, Jalil A, Tanoli AK, Hasan KA, Naz S, Kashif M, Zaidi NF, Khan A, Vohra Z, Ralf H, Qaiser S.   +13 more
europepmc   +1 more source

Sacubitril/valsartan facilitates recovery of cardiac function in a patient with peripartum cardiomyopathy: a case report. [PDF]

Eur Heart J Case Rep
Saijo Y, Yamada H, Yagi S, Yoshida A, Sata M.   +4 more
europepmc   +1 more source

Reply to 'Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways'. [PDF]

Eur Heart J Cardiovasc Pharmacother
Jung K, Shin JY, Kim JH.
europepmc   +1 more source

Ten years real-world experience with sacubitril/valsartan in patients with heart failure with reduced ejection fraction. [PDF]

ESC Heart Fail
Savarese G, Basile C, Mebazaa A, Bayes-Genis A, Kang SM, Yoo BS, Eid C, Bozkurt B, Butler J.   +8 more
europepmc   +1 more source

Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways. [PDF]

Eur Heart J Cardiovasc Pharmacother
Dong W, Li W.
europepmc   +1 more source

Effects of sacubitril/valsartan on ventricular remodeling in patients with hypertension and maintenance hemodialysis: a retrospective cohort study. [PDF]

Front Cardiovasc Med
Jiang L, Min X, Ran J, Zhu Y, Pan L, Yang B, Ran X, Ran Y, Ding H, Yang J, Wu S.   +10 more
europepmc   +1 more source

Angioedema After Accidental Semaglutide Dosing Error: A Case Report. [PDF]

J Clin Med
Kraft BD, Matuszak S.
europepmc   +1 more source

Cost-Effectiveness of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors by Ejection Fraction and Drug Pricing in the United States: A Systematic Review. [PDF]

Circ Popul Health Outcomes
Alfie TJ, Wasfy JH, Kazi DS, Januzzi JL, Bellows BK, Cohen LP.   +5 more
europepmc   +1 more source

Bleeding Disorder, A Newly Recognized Adverse Event Following Sacubitril/Valsartan Therapy. [PDF]

Eur J Case Rep Intern Med
Al-Omari YW, Mustafa SA, Saleh AH, Abdel-Razaq WS.   +3 more
europepmc   +1 more source